NewcelX Ltd. (NCEL) News
Track canonical SquawkNews coverage tagged to NCEL, NewcelX Ltd.. This hub brings together deduplicated headlines about alpaca us equities, markets catalysts, earnings, analyst actions, and wider market events so traders can review how a developing story changed over time. It contains 2 indexed stories across 2 publication days and is ordered by the same first-publication timeline used by LiveCast.
H
NCEL Prices $1.4M Equity Financing
NCEL prices equity financing at 20% premium
EQUITY | Jul 31, 2026, 01:00 PM UTC
L
NewcelX Completes Type B Pre-IND Meeting With FDA; Administration Provided Constructive Feedback And Alignment On Proposed Strategy
The FDA provided clarity regarding the regulatory pathway toward launching a clinical trial of NCEL-101 for type 1 diabetes in combination with Eledon Pharmaceuticals’ (NASDAQ: ELDN ) anti-CD40L antibody, tegoprubart, an
REGULATION | Jul 01, 2026, 01:33 PM UTC